CEO Jeff Galvin Addresses Congress on the Biotechnology Investment Tax Credit

CEO Jeff Galvin Addresses Congress on the Biotechnology Investment Tax Credit

Jeff Galvin, CEO of American Gene Technologies® provided testimony in a Senate Hearing on March 8, 2016 in support of Maryland’s Biotechnology Investment Incentive Tax Credit. His goal? To alter the definition of “qualified Maryland biotechnology company” so that an active business may claim the biotechnology tax credit – empowering gene therapy startups in the state of Maryland.

youtube-video-thumbnail

Subscribe to Receive our Blog Updates

Subscribe to our blog updates to be notified when we release new content!